Mangalam Drugs & Organics Limited (BOM:532637)
India
· Delayed Price · Currency is INR 33.17
-0.81 (-2.38%)
At close: Mar 10, 2026
Mangalam Drugs & Organics Revenue
Mangalam Drugs & Organics had revenue of 583.76M INR in the quarter ending December 31, 2025, a decrease of -34.08%. This brings the company's revenue in the last twelve months to 2.38B, down -31.47% year-over-year. In the fiscal year ending March 31, 2025, Mangalam Drugs & Organics had annual revenue of 3.18B, down -13.55%.
Revenue (ttm)
2.38B
Revenue Growth
-31.47%
P/S Ratio
0.23
Revenue / Employee
4.95M
Employees
480
Market Cap
537.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.18B | -497.78M | -13.55% |
| Mar 31, 2024 | 3.67B | -28.42M | -0.77% |
| Mar 31, 2023 | 3.70B | -806.66M | -17.89% |
| Mar 31, 2022 | 4.51B | 708.84M | 18.65% |
| Mar 31, 2021 | 3.80B | 976.24M | 34.57% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biofil Chemicals and Pharmaceuticals | 322.66M |
| Shelter Pharma | 598.96M |
| Phaarmasia | 449.06M |
| Onyx Biotec | 663.87M |
| Rajnish Wellness | 455.79M |
| Walpar Nutritions | 757.46M |
| Godavari Drugs | 986.94M |
| Panjon | 493.34M |